Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta2-spectrin (also known as βII-spectrin) is a cytoskeletal protein that forms part of the spectrin family, characterized by its ability to cross-link actin filaments beneath the plasma membrane, thus creating a flexible, elastic membrane skeleton[3]. In neurons, βII-spectrin is essential for establishing the periodic actin–spectrin skeleton, which promotes both axon growth and stability, and enables efficient bidirectional transport of organelles within axons[1]. It interacts directly with motor proteins such as kinesins (KIF3A, KIF5B, KIF1A) and the dynein/dynactin complex, coupling them to membranes likely via phosphoinositide lipid binding[1]. In the heart, βII-spectrin is critical for the correct localization of key membrane proteins involved in calcium handling and electrical activity, such as the Na/Ca exchanger, Na/K ATPase, and ryanodine receptor 2[2]. Deficiency in βII-spectrin leads to severe arrhythmias, aberrant calcium handling, and accelerated heart failure in mice, as well as the mislocalization of ankyrin-B–associated membrane protein complexes[2]. In synapses, βII-spectrin differentially associates with certain GABA_A receptor subtypes, regulating their accumulation and thus the efficacy of fast inhibitory neurotransmission[4]. Apoptotic cleavage of βII-spectrin by caspase-3/7 has been reported, suggesting a regulatory role in cell death[5]. βII-spectrin is not currently a direct therapeutic target in clinical practice but is a critical molecular player in both neuronal and cardiac pathophysiology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta2-spectrin (βII-spectrin).